Drugs / Fibryga
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04534751 | Apr 2021 → Dec 2023 | blood coagulation disease | University Health Network, Toronto | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fibryga | “Intervention group: 4 g Fibryga and 2000 IU Octaplex will be released as part of the first and second MHP packs.” NCT04534751 ↗ |